NO874490L - Kloning og anvendelse av transaminasegenet ilv-e. - Google Patents
Kloning og anvendelse av transaminasegenet ilv-e.Info
- Publication number
- NO874490L NO874490L NO874490A NO874490A NO874490L NO 874490 L NO874490 L NO 874490L NO 874490 A NO874490 A NO 874490A NO 874490 A NO874490 A NO 874490A NO 874490 L NO874490 L NO 874490L
- Authority
- NO
- Norway
- Prior art keywords
- gene
- dna
- coli
- ilve
- microorganism
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title claims description 16
- 238000010367 cloning Methods 0.000 title description 8
- 238000005891 transamination reaction Methods 0.000 title description 2
- 241000588724 Escherichia coli Species 0.000 claims description 38
- 101150099953 ilvE gene Proteins 0.000 claims description 34
- 108090000340 Transaminases Proteins 0.000 claims description 28
- 102000003929 Transaminases Human genes 0.000 claims description 26
- 239000013612 plasmid Substances 0.000 claims description 17
- 125000001931 aliphatic group Chemical group 0.000 claims description 11
- 244000005700 microbiome Species 0.000 claims description 10
- 230000002759 chromosomal effect Effects 0.000 claims description 8
- 150000005693 branched-chain amino acids Chemical class 0.000 claims description 4
- 238000005576 amination reaction Methods 0.000 claims description 3
- 238000012261 overproduction Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 230000003362 replicative effect Effects 0.000 claims description 2
- 108020004414 DNA Proteins 0.000 description 45
- 239000000203 mixture Substances 0.000 description 20
- 239000012634 fragment Substances 0.000 description 18
- 230000000694 effects Effects 0.000 description 14
- 102000004190 Enzymes Human genes 0.000 description 13
- 108090000790 Enzymes Proteins 0.000 description 13
- 229940024606 amino acid Drugs 0.000 description 12
- 235000001014 amino acid Nutrition 0.000 description 12
- 230000029087 digestion Effects 0.000 description 11
- 108091008146 restriction endonucleases Proteins 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 150000001413 amino acids Chemical class 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 238000002955 isolation Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 101150028338 tyrB gene Proteins 0.000 description 6
- 229930194542 Keto Natural products 0.000 description 5
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 5
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 5
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 5
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 5
- 239000004098 Tetracycline Substances 0.000 description 5
- 238000000246 agarose gel electrophoresis Methods 0.000 description 5
- 101150005925 aspC gene Proteins 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 229960000310 isoleucine Drugs 0.000 description 5
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 5
- 125000000468 ketone group Chemical group 0.000 description 5
- 239000002243 precursor Substances 0.000 description 5
- 229960002180 tetracycline Drugs 0.000 description 5
- 229930101283 tetracycline Natural products 0.000 description 5
- 235000019364 tetracycline Nutrition 0.000 description 5
- 150000003522 tetracyclines Chemical class 0.000 description 5
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 4
- 101100492609 Talaromyces wortmannii astC gene Proteins 0.000 description 4
- 101150116772 aatA gene Proteins 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 101150100742 dapL gene Proteins 0.000 description 4
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 4
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 3
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 102000012410 DNA Ligases Human genes 0.000 description 3
- 108010061982 DNA Ligases Proteins 0.000 description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- 239000007984 Tris EDTA buffer Substances 0.000 description 3
- -1 aliphatic amino acids Chemical class 0.000 description 3
- 229960000723 ampicillin Drugs 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 230000026683 transduction Effects 0.000 description 3
- 238000010361 transduction Methods 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 229940009098 aspartate Drugs 0.000 description 2
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 229930195712 glutamate Natural products 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000588914 Enterobacter Species 0.000 description 1
- 241001646716 Escherichia coli K-12 Species 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 241000702208 Shigella phage SfX Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000005275 alloying Methods 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 210000003578 bacterial chromosome Anatomy 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000007169 ligase reaction Methods 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1096—Transferases (2.) transferring nitrogenous groups (2.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/06—Alanine; Leucine; Isoleucine; Serine; Homoserine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/08—Lysine; Diaminopimelic acid; Threonine; Valine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/848—Escherichia
- Y10S435/849—Escherichia coli
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19863636722 DE3636722A1 (de) | 1986-10-29 | 1986-10-29 | Klonierung und verwendung des transaminase-gens ilve |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO874490D0 NO874490D0 (no) | 1987-10-28 |
| NO874490L true NO874490L (no) | 1988-05-02 |
Family
ID=6312683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO874490A NO874490L (no) | 1986-10-29 | 1987-10-28 | Kloning og anvendelse av transaminasegenet ilv-e. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5120654A (fi) |
| EP (1) | EP0265852A3 (fi) |
| JP (1) | JPS63129986A (fi) |
| KR (1) | KR880005271A (fi) |
| CN (1) | CN87107205A (fi) |
| AU (1) | AU8042587A (fi) |
| CA (1) | CA1340676C (fi) |
| DE (1) | DE3636722A1 (fi) |
| DK (1) | DK565487A (fi) |
| FI (1) | FI874725A (fi) |
| IE (1) | IE872891L (fi) |
| IL (1) | IL84293A0 (fi) |
| NO (1) | NO874490L (fi) |
| PT (1) | PT86034B (fi) |
| ZA (1) | ZA878081B (fi) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3752311D1 (de) * | 1986-06-04 | 2000-04-27 | Hoechst Schering Agrevo Gmbh | Verfahren zur Herstellung von L-tertiär-Leucin durch Transaminierung |
| DE3818851A1 (de) * | 1988-06-03 | 1989-12-14 | Hoechst Ag | Neue transaminase, ihre herstellung und ihre verwendung |
| DE3932015A1 (de) * | 1988-12-15 | 1991-04-04 | Hoechst Ag | Gen und genstruktur, codierend fuer eine aminotransferase, mikroorganismen, die dieses gen exprimieren, und transaminierungsverfahren unter verwendung des expressionsprodukts |
| RU2243260C2 (ru) * | 2002-06-25 | 2004-12-27 | Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" | Способ получения l-лейцина (варианты), штамм escherichia coli 505/pacyc-tyr b - продуцент l-лейцина |
| RU2015120052A (ru) * | 2015-05-28 | 2016-12-20 | Аджиномото Ко., Инк. | Способ получения L-аминокислоты с использованием бактерии семейства Enterobacteriaceae, в которой ослаблена экспрессия гена gshA |
| KR102143964B1 (ko) * | 2019-12-06 | 2020-08-12 | 씨제이제일제당 주식회사 | 신규한 분지쇄 아미노산 아미노트랜스퍼라제 변이체 및 이를 이용한 류신 생산방법 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8301700D0 (en) * | 1983-01-21 | 1983-02-23 | Searle & Co | Cloning and utilisation of aminotransferase genes |
| GB8403244D0 (en) * | 1984-02-07 | 1984-03-14 | Searle & Co | Aminoacids via bioconversion |
| EP0189938A2 (en) * | 1985-02-01 | 1986-08-06 | G.D. Searle & Co. | Process for the preparation of L-DOPA |
-
1986
- 1986-10-29 DE DE19863636722 patent/DE3636722A1/de not_active Withdrawn
-
1987
- 1987-10-23 EP EP87115528A patent/EP0265852A3/de not_active Withdrawn
- 1987-10-27 IL IL84293A patent/IL84293A0/xx unknown
- 1987-10-27 FI FI874725A patent/FI874725A/fi not_active Application Discontinuation
- 1987-10-28 IE IE872891A patent/IE872891L/xx unknown
- 1987-10-28 DK DK565487A patent/DK565487A/da not_active Application Discontinuation
- 1987-10-28 CA CA000550516A patent/CA1340676C/en not_active Expired - Fee Related
- 1987-10-28 CN CN198787107205A patent/CN87107205A/zh active Pending
- 1987-10-28 AU AU80425/87A patent/AU8042587A/en not_active Abandoned
- 1987-10-28 ZA ZA878081A patent/ZA878081B/xx unknown
- 1987-10-28 NO NO874490A patent/NO874490L/no unknown
- 1987-10-29 PT PT86034A patent/PT86034B/pt not_active IP Right Cessation
- 1987-10-29 KR KR870011999A patent/KR880005271A/ko not_active Application Discontinuation
- 1987-10-29 JP JP62274613A patent/JPS63129986A/ja active Pending
-
1990
- 1990-08-13 US US07/566,320 patent/US5120654A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ZA878081B (en) | 1988-10-26 |
| PT86034B (pt) | 1990-08-31 |
| CA1340676C (en) | 1999-07-27 |
| AU8042587A (en) | 1988-05-05 |
| NO874490D0 (no) | 1987-10-28 |
| EP0265852A2 (de) | 1988-05-04 |
| PT86034A (de) | 1987-11-01 |
| IL84293A0 (en) | 1988-03-31 |
| DK565487A (da) | 1988-04-30 |
| CN87107205A (zh) | 1988-07-20 |
| FI874725A0 (fi) | 1987-10-27 |
| US5120654A (en) | 1992-06-09 |
| FI874725A (fi) | 1988-04-30 |
| DK565487D0 (da) | 1987-10-28 |
| IE872891L (en) | 1988-04-29 |
| JPS63129986A (ja) | 1988-06-02 |
| DE3636722A1 (de) | 1988-05-05 |
| KR880005271A (ko) | 1988-06-28 |
| EP0265852A3 (de) | 1988-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Richter et al. | Biosynthesis of riboflavin: cloning, sequencing, and expression of the gene coding for 3, 4-dihydroxy-2-butanone 4-phosphate synthase of Escherichia coli | |
| NO169180B (no) | Fremgangsmaate til fremstilling av l-tert-leucin og l-fosfinotricin ved transaminering | |
| Lévêque et al. | Control of Escherichia coli lysyl-tRNA synthetase expression by anaerobiosis | |
| US5091314A (en) | Cloning and use of transaminase gene tyrb | |
| NO874490L (no) | Kloning og anvendelse av transaminasegenet ilv-e. | |
| RU2133773C1 (ru) | Гены бутиробетаин/кротонобетаин-l-карнитин-метаболизма и их применение для микробиологического получения l-карнитина | |
| US5096823A (en) | Cloning of the bioa, biod, biof, bioc and bioh genes of bacillus spraericus, vectors and transformed cells | |
| Oguiza et al. | A gene encoding arginyl-tRNA synthetase is located in the upstream region of the lysA gene in Brevibacterium lactofermentum: regulation of argS-lysA cluster expression by arginine | |
| Stuible et al. | Identification and functional differentiation of two type I fatty acid synthases in Brevibacterium ammoniagenes | |
| CA2083407C (en) | Microorganisms for the stabilization of plasmids | |
| EP0537553B1 (en) | Farnesyl pyrophosphate synthetase and DNA sequence encoding the same | |
| US5243039A (en) | Bacillus MGA3 aspartokinase II gene | |
| US4861717A (en) | Microorganisms and plasmids for the constitutive formation of creatinamidinohydrolase and processes for the production thereof | |
| AU610395B2 (en) | Cloned tryptophan synthase gene and recombinant plasmid containing the same | |
| EP0450920B1 (en) | Cloned tyrosine phenol-lyase gene, recombinant plasmid containing it and E. coli transformed with the plasmid | |
| JP4162383B2 (ja) | ホモグルタミン酸の生産に関与する遺伝子およびその使用 | |
| JPH11137254A (ja) | バチルス属細菌由来のトランスグルタミナーゼの製造法 | |
| AU2002241272B2 (en) | Transformant producing PF1022 substance derivatives, process for producing the same and novel biosynthesis gene | |
| Sugino et al. | Gene cloning of the maoA gene and overproduction of a soluble monoamine oxidase from Klebsiella aerogenes | |
| CN1590546B (zh) | 含生物素生物合成基因的dna片段及其利用 | |
| Robinson et al. | Cloning of the gene coding for aromatic amino acid aminotransferase from an E. Coli B strain | |
| US20020010136A1 (en) | Mutant tyrosine repressor gene and utilization thereof | |
| RU2314346C2 (ru) | Плазмиды для хромосомной рекомбинации escherichia coli | |
| Magnouloux-Blanc et al. | Overproduction and excretion of β-lactamase and alkaline phosphatase by Escherichia coli olp mutants | |
| JPS62143691A (ja) | アミノ酸の製造法 |